There was no statistically significant difference in myocardial infarction, revascularization of target coronary artery, and severe cardiovascular events between the group FFR ≤ 0.8 with PCI and the group FFR > 0.8 with medical therapy (p = 0.79); and there was no statistically significant difference in survival between two groups (p=0.1).